{
    "2019-03-08": [
        [
            {
                "time": "2018-03-05",
                "original_text": "Gilead Reports Positive Data on HIV Drugs Biktarvy & Descovy",
                "features": {
                    "keywords": [
                        "Gilead",
                        "Positive Data",
                        "HIV Drugs",
                        "Biktarvy",
                        "Descovy"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2019-02-15",
                "original_text": "How Novartis Is Transforming Its Structure in 2019",
                "features": {
                    "keywords": [
                        "Novartis",
                        "Transforming",
                        "Structure"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-04-10",
                "original_text": "Dutch join backlash at expensive drugs by making their own",
                "features": {
                    "keywords": [
                        "Dutch",
                        "backlash",
                        "expensive drugs",
                        "own production"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}